AKT1 and atherosclerosis: The results of KEGG pathway enrichment analysis showed that Epimedium achieves HF regulation through related disease pathways and signaling pathways, such as lipid and atherosclerosis, PI3K/Akt signaling pathway, and Chemical carcinogenesis-receptor activation.